U.S. Markets close in 1 hr 31 mins

Edesa Biotech, Inc. (EDSA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
6.20-0.13 (-2.05%)
As of 2:24PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 319.10
52 Week Low 31.58
50-Day Moving Average 37.53
200-Day Moving Average 35.47

Share Statistics

Avg Vol (3 month) 31.04M
Avg Vol (10 day) 3540.78k
Shares Outstanding 59.61M
Float 3.7M
% Held by Insiders 146.77%
% Held by Institutions 124.89%
Shares Short (Sep 29, 2020) 497.8k
Short Ratio (Sep 29, 2020) 40.31
Short % of Float (Sep 29, 2020) 42.09%
Short % of Shares Outstanding (Sep 29, 2020) 41.02%
Shares Short (prior month Aug 30, 2020) 4104.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jun 09, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep 29, 2019
Most Recent Quarter (mrq)Jun 29, 2020


Profit Margin 0.00%
Operating Margin (ttm)-673.76%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)875.63k
Revenue Per Share (ttm)0.10
Quarterly Revenue Growth (yoy)21,897.00%
Gross Profit (ttm)412.78k
Net Income Avi to Common (ttm)-5.86M
Diluted EPS (ttm)-0.73
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.64M
Total Cash Per Share (mrq)0.6
Total Debt (mrq)176.88k
Total Debt/Equity (mrq)2.27
Current Ratio (mrq)6.33
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-5.87M
Levered Free Cash Flow (ttm)N/A